Cervical Cancer Home > Cervarix Vaccine Information

Cervarix® (Human Papillomavirus Bivalent [Types 16 and 18] Vaccine, Recombinant) is one of two available HPV vaccines. It is approved for females age 10 through 25, and is used to prevent cervical cancer caused by certain types of human papillomavirus (HPV). The vaccine can also prevent certain precancerous cervical lesions. However, Cervarix is not designed to provide protection against the types of HPV most likely to cause genital warts.
There are many different HPV viruses, and Cervarix does not protect against all of them. However, it does protect against two important types responsible for 70 percent of cervical cancers.
The most common side effects seen with Cervarix include:
  • Injection site reactions
  • Headache
  • Fatigue.
This vaccine is typically given as three separate injections within a six-month period. Before receiving Cervarix, discuss the vaccine's safety precautions with your healthcare provider. This product may not be suitable for everyone, so let your healthcare provider know about any medications you take and any medical conditions you have.
(For more information on this vaccine, click Cervarix. This article takes a closer look at this product, with a discussion on how it works, available forms, aluminum content, and more.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.